Risk factors for venous thromboembolic events in cancer patients.
about
Venous thromboembolic diseaseVenous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer AnticoagulantsBiomolecular markers of cancer-associated thromboembolismVenous thromboembolism in the cancer population: pathology, risk, and preventionPredictors of venous thromboembolism in patients with advanced common solid cancersImplementing thrombosis guidelines in cancer patients: a review.Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancerIncreased expressions of integrin subunit β1, β2 and β3 in patients with cancer ------correlation analysis between risk factors of VTE and expression of core proteins.Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study.Tamoxifen alters the plasma concentration of molecules associated with cardiovascular risk in women with breast cancer undergoing chemotherapyPattern of Venous Thrombosis in Cancer Patients: Frequency and Survival Effect; Single Center Experience.Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancerCancer and coagulation.Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.Elevated preoperative plasma D-dimer levels and the incidence of venous thromboembolism in Japanese females with gynecological cancer.Erythropoietin update 2011Upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: a retrospective analysis of risk factors.Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States.Development and validation of a predictive model for chemotherapy-associated thrombosis.IVC filters may prevent fatal pulmonary embolism in musculoskeletal tumor surgery.The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.Epidemiology of cancer-related venous thromboembolism.New insights into cancer-associated thrombosis.Treatment with Huisheng oral solution inhibits the development of pulmonary thromboembolism and metastasis in mice with Lewis lung carcinomaAssessing risk of venous thromboembolism in the patient with cancer.Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.Thrombophilic state in cancer, part I: biology, incidence, and risk factors.Identification of patient venous thromboembolism risk across the continuum of care.Risk assessment models for cancer-associated venous thromboembolism.Clinical models and biochemical predictors of VTE in lung cancer.Venous Thromboembolism in Patients Diagnosed With Lung Cancer.Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide.Presence of varicose veins in cancer patients increases the risk for occurrence of venous thromboembolism.Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer.Which Patients Require Extended Thromboprophylaxis After Colectomy? Modeling Risk and Assessing Indications for Post-discharge Pharmacoprophylaxis.Risk factors associated with mortality from vascular thromboembolic events in patients diagnosed with non-small cell lung cancer: A population-based analysis.Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
P2860
Q24631121-0546BC0D-0947-4B2D-98FF-9947FF389E2AQ26741697-DC8E2D8A-3260-4B23-AFC6-04F7D3C5CEE8Q26865716-DD9C1F66-F200-4DA4-9B11-60D12717C674Q26996508-9F1FD088-DC18-4E5B-B3E4-99258BA04589Q33810510-29237839-9678-4436-9166-1E451FB03782Q34463482-D7EA902C-16C6-444C-BA41-5D8BDF6708ABQ35432469-AFE6B278-4829-4398-BF4D-D90A1571EB08Q35481286-18842420-B385-40B1-BEA3-DF31D2823020Q35563035-841E2F6D-FBF3-466B-A741-FB7077DF7863Q35913219-C9B5BC1A-D046-420A-A2A8-06C8E47C161EQ35975031-AE8EEBB9-533E-49FC-BCBC-861AB1527E80Q36251473-A7B394BD-1507-48AF-A48F-D15039504D29Q36391554-C9CD8CFD-5ADC-4FEB-9AE7-5DBE79551556Q36406741-B89E24CB-D370-4255-B9BA-703E398C784DQ36475949-2C9E5333-37BB-45A9-9ABA-4C137EA78F0AQ36516298-F41FBBA7-2167-40C6-97A7-FE89523CC8E8Q36534826-6E047B09-438D-4DCF-884E-71B6C8781726Q36617694-7727DB09-AF08-4B58-8A47-73D69801BCE6Q36657982-9AAA117D-E99B-4115-9D41-FCF7093CB755Q37011663-DA187A2A-D66D-4DCA-8B58-B1FC2B3902E3Q37187791-E30CFD18-ED35-4BEE-88B6-4EA53B7D4DC0Q37242472-A046696E-C43A-473D-8966-9DFB1169A3AEQ37307380-57C316C5-575B-439D-9A00-B4D303C5F6B6Q37388646-BC65E6E9-F284-4CFF-A9AE-111D138BBDB8Q37393394-F2A62FEB-6E1C-4EF9-8F92-31903F683C01Q37416512-DD804466-2DEE-4933-B0E5-7104727F0060Q37863640-A5653B83-D1C9-4B90-A601-AC6D8D66866DQ37877058-67F7A836-EAC3-47C5-9606-B508A8D7C9B2Q37956590-D75B8945-8160-4361-94AA-293768E85F69Q38205701-41D0E06B-0934-4A68-A2C7-85B1120428AAQ38944457-44E874AE-6DE4-41D0-9441-C7331D1DA776Q40217071-ACC47FD3-8023-47F6-AE4E-4E8AC45AF012Q40824665-A9A66A05-822C-4128-8E51-F12BFBD7AD36Q44376211-3C27B3BD-1F84-4E04-AB33-9E63162FA2CFQ45711211-69EAFDEA-98AD-4B68-A965-2259F5F78215Q47156509-6DBF139B-F7C9-45D8-8F66-77C6F1E71C3CQ47568371-FCD62736-4D60-4C38-B41A-B67C4DC4ED00Q47612008-81C5793D-C13A-458B-BF2D-07BCCB65C74FQ49909927-2D08650E-662E-4FFF-A461-FBB89724E7F2Q53275633-5F2A6EF5-1AA7-4515-BE8E-75269C4A7F95
P2860
Risk factors for venous thromboembolic events in cancer patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Risk factors for venous thromboembolic events in cancer patients.
@en
type
label
Risk factors for venous thromboembolic events in cancer patients.
@en
prefLabel
Risk factors for venous thromboembolic events in cancer patients.
@en
P2093
P2860
P356
P1433
P1476
Risk factors for venous thromboembolic events in cancer patients.
@en
P2093
K Urbanski
M E Scheulen
P2860
P304
P356
10.1093/ANNONC/MDJ068
P577
2005-11-09T00:00:00Z